Related Experiment Video
Updated: Jan 13, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Advancing translational science through trial integrity: REDCap-based approaches to mitigating fraud and bias
Gaylen E Fronk1, Larry W Hawk2, Andrew Cates3
1Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
None:
Decentralized clinical trials (DCTs) have the potential to increase pace and reach of recruitment as well as to improve sample representation, compared to traditional in-person clinical trials. However, concerns linger regarding data integrity in DCTs due to threats of fraud and sampling bias. The purpose of this report is to describe two tools that we have developed and successfully implemented to combat these threats. Cheatblocker and QuotaConfig are two external modules that we have made publicly available within the REDCap data capture system to target fraud and sampling bias, respectively. We describe the modules, present two case examples in which we used the modules successfully, and discuss the potential impact of tools such as these on data integrity in DCTs. We situate this discussion within the broader landscape of translational science wherein we strive to improve research rigor and efficiency to maximize public health benefit.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Improving Translational Accuracy
Improving Translational Accuracy
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blinding

